Literature DB >> 20413278

Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study.

Stephen J Wood1, Luca Cocchi, Tina-Marie Proffitt, Mirabel McConchie, Graeme D Jackson, Tsutomu Takahashi, Christos Pantelis, Patrick D McGorry, Gregor E Berger.   

Abstract

We used magnetic resonance imaging to examine the effect of ethyl-eicosapentaenoic acid (E-EPA) on hippocampal T(2) relaxation time in first episode psychosis patients at baseline and after 12 weeks of follow-up. There was an increase in T(2) in the placebo group but not in the E-EPA group, suggesting a neuroprotective effect of E-EPA treatment. In addition, the smaller the increase in T(2), the greater the improvement in negative symptoms. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20413278     DOI: 10.1016/j.pscychresns.2009.12.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  14 in total

Review 1.  Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging.

Authors:  Robert K McNamara
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-04-21       Impact factor: 4.006

2.  Rapid simultaneous high-resolution mapping of myelin water fraction and relaxation times in human brain using BMC-mcDESPOT.

Authors:  Mustapha Bouhrara; Richard G Spencer
Journal:  Neuroimage       Date:  2016-10-08       Impact factor: 6.556

3.  Early psychosis research at Orygen, The National Centre of Excellence in Youth Mental Health.

Authors:  S M Cotton; K M Filia; A Ratheesh; K Pennell; S Goldstone; P D McGorry
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2016-01       Impact factor: 4.328

Review 4.  (N-3) Fatty acids: molecular role and clinical uses in psychiatric disorders.

Authors:  Pedro Luis Prior; José Carlos Fernandes Galduróz
Journal:  Adv Nutr       Date:  2012-05-01       Impact factor: 8.701

5.  Improved determination of the myelin water fraction in human brain using magnetic resonance imaging through Bayesian analysis of mcDESPOT.

Authors:  Mustapha Bouhrara; Richard G Spencer
Journal:  Neuroimage       Date:  2015-10-22       Impact factor: 6.556

Review 6.  The promise of biological markers for treatment response in first-episode psychosis: a systematic review.

Authors:  Guillaume Fond; Marc-Antoine d'Albis; Stéphane Jamain; Ryad Tamouza; Celso Arango; W Wolfgang Fleischhacker; Birte Glenthøj; Markus Leweke; Shôn Lewis; Phillip McGuire; Andreas Meyer-Lindenberg; Iris E Sommer; Inge Winter-van Rossum; Shitij Kapur; René S Kahn; Dan Rujescu; Marion Leboyer
Journal:  Schizophr Bull       Date:  2015-03-10       Impact factor: 9.306

7.  Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.

Authors:  Gregor E Berger; Stefan Smesny; Miriam R Schäfer; Berko Milleit; Kerstin Langbein; Uta-Christina Hipler; Christine Milleit; Claudia M Klier; Monika Schlögelhofer; Magdalena Holub; Ingrid Holzer; Michael Berk; Patrick D McGorry; Heinrich Sauer; G Paul Amminger
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240

8.  Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics.

Authors:  Joseph McEvoy; Rebecca A Baillie; Hongjie Zhu; Peter Buckley; Matcheri S Keshavan; Henry A Nasrallah; George G Dougherty; Jeffrey K Yao; Rima Kaddurah-Daouk
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

9.  Multi-compartment T2 relaxometry using a spatially constrained multi-Gaussian model.

Authors:  Ashish Raj; Sneha Pandya; Xiaobo Shen; Eve LoCastro; Thanh D Nguyen; Susan A Gauthier
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

10.  Comments on Bozzatello et al. Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data. J. Clin. Med. 2016, 5, 67.

Authors:  Gregor Berger
Journal:  J Clin Med       Date:  2016-08-03       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.